Delivery Order SPE2DB24D2205-SPE2DB25FEBWA

Award Date 5/5/25
Potential Completion Date 5/6/25
Potential Value $101K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the delivery of TWINRIX VACCINE SYRINGEml, a hepatitis A and hepatitis B vaccine, with a ceiling value of $1,078.23 and a period of performance through April 2025. The contract is not set aside and was competitively awarded. AmerisourceBergen Drug Corp holds a large Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major supplier of pharmaceutical products and medical supplies to the U.S. federal government. The $20,282.40 firm fixed-price contract is for the delivery of TWINRIX VACCINE SYRINGE ML, a combination vaccine used to prevent hepatitis A and hepatitis B. The contract has an ultimate completion date of August 6, 2024. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs)...
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $37,882.20, is for the delivery of TWINRIX VACCINE SYRINGEML and has a completion date of May 24, 2024. The contract is a Firm Fixed Price arrangement and was not set aside for any specific business type. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of 4,567,943,053 units of the TWINRIX VACCINE SYRINGE ML product, with a ceiling value of $9,732.89. The contract is a firm fixed-price, non-set-aside award with an ultimate completion date of April 17, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,438.37, is for the delivery of TWINRIX VACCINE SYRINGEML, a vaccine product. The contract is a Firm Fixed Price Delivery Order, with an ultimate completion date of January 8, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and B vaccine, at a ceiling value of $1,481.68. The contract has a firm fixed price pricing type and an ultimate completion date of March 13, 2025. The contract is not designated with a set-aside. Amerisourcebergen Drug Corp is the prime...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $131,101.44 firm fixed-price delivery order is for the supply of TWINRIX vaccine syringes. The contract has an ultimate completion date of July 15, 2024 and was awarded on July 12, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of TWINRIX vaccine syringes. The contract has a Firm Fixed Price pricing type and a ceiling value of $5,125.68, with an ultimate completion date of October 10, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the procurement of TWINRIX Vaccine syringes, a vaccine used for the prevention of hepatitis A and hepatitis B. The contract has a ceiling value of $2,705.52 and runs through February 8, 2024. It is a firm-fixed-price contract, and there is no set-aside designation, indicating open competition....
This federal contract award, valued at $65,550.72, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is a delivery order for the supply of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract has an ultimate completion date of June 11, 2024 and is a firm fixed-price contract. AmerisourceBergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
  • SPE2DB24D2205
    Indefinite Delivery Contract
  • SPE2DB24D2205-SPE2DB25FEBWA
    Delivery Order

This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $100,636.46, is for the delivery of TWINRIX VACCINE SYRINGEML, a hepatitis A and hepatitis B vaccine. The contract is a firm fixed-price, non-set-aside award with a performance period ending on May 6, 2025.

AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive global pharmaceutical support vehicle through December 2026. This enables the company to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including for the Defense Health Agency and U.S. Coast Guard.

Generated 8/4/25, 9:50 AM